Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan · Delayed Price · Currency is TWD 131.00
-0.50 (-0.38%)
At close: Mar 27, 2026
TPEX:3218 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,043 | 1,065 | 1,045 | 850.53 | 595.43 |
Depreciation & Amortization | 541.41 | 518.05 | 441.77 | 367.85 | 315.1 |
Other Amortization | 2.38 | 3.44 | 4.38 | 4.41 | 4.42 |
Loss (Gain) From Sale of Assets | 0.62 | 8.92 | 1.37 | 2.22 | 0.22 |
Asset Writedown & Restructuring Costs | 16.17 | - | - | - | - |
Loss (Gain) From Sale of Investments | 61.89 | 100.22 | - | - | - |
Provision & Write-off of Bad Debts | -3.07 | 2.44 | 4.36 | 7.65 | 0.32 |
Other Operating Activities | 28.63 | -20.24 | 65.66 | 83.06 | 38.42 |
Change in Accounts Receivable | 54.32 | 16.1 | -6.76 | -54.54 | -158.12 |
Change in Inventory | -13.84 | 1.8 | -89.85 | -111.63 | -47.32 |
Change in Accounts Payable | -43.71 | -44.24 | 57.76 | 44.06 | 87.56 |
Change in Other Net Operating Assets | -21 | 20.85 | 29.82 | 74.57 | 75.74 |
Operating Cash Flow | 1,666 | 1,672 | 1,554 | 1,268 | 911.77 |
Operating Cash Flow Growth | -0.34% | 7.63% | 22.51% | 39.09% | 10.24% |
Capital Expenditures | -562.66 | -434.65 | -472.53 | -489.7 | -324.44 |
Sale of Property, Plant & Equipment | 0.11 | 0.86 | 0.08 | 0.12 | 0.07 |
Sale (Purchase) of Intangibles | -1.16 | -2.45 | -1.68 | -3.14 | -4.26 |
Investment in Securities | 22.06 | -1,046 | -1.74 | -70.81 | -44.06 |
Other Investing Activities | -1.94 | -1.93 | -1.08 | -1.14 | -7.11 |
Investing Cash Flow | -543.59 | -1,484 | -476.95 | -564.66 | -379.81 |
Short-Term Debt Issued | 48.61 | 82.52 | 8.85 | - | - |
Long-Term Debt Issued | - | - | - | - | 23.88 |
Total Debt Issued | 48.61 | 82.52 | 8.85 | - | 23.88 |
Short-Term Debt Repaid | -46.36 | - | - | - | -176.49 |
Long-Term Debt Repaid | -204.53 | -185.43 | -177.84 | -164.22 | -140.03 |
Total Debt Repaid | -250.9 | -185.43 | -177.84 | -164.22 | -316.52 |
Net Debt Issued (Repaid) | -202.29 | -102.91 | -168.99 | -164.22 | -292.64 |
Common Dividends Paid | -635.44 | -593.07 | -479.58 | -380.62 | -319.72 |
Other Financing Activities | -7.5 | -67.06 | -62.09 | 5 | 0.03 |
Financing Cash Flow | -845.23 | -763.04 | -710.65 | -539.83 | -612.33 |
Foreign Exchange Rate Adjustments | -5.24 | 19.41 | -6.46 | 5.14 | -1.45 |
Net Cash Flow | 272.39 | -555.69 | 359.53 | 168.83 | -81.81 |
Free Cash Flow | 1,104 | 1,237 | 1,081 | 778.47 | 587.33 |
Free Cash Flow Growth | -10.80% | 14.46% | 38.87% | 32.55% | 10.41% |
Free Cash Flow Margin | 26.25% | 29.27% | 26.48% | 22.28% | 22.32% |
Free Cash Flow Per Share | 12.98 | 14.56 | 12.73 | 9.17 | 6.92 |
Cash Interest Paid | 5.26 | 5.05 | 1.47 | 1.21 | 2.47 |
Cash Income Tax Paid | 299.11 | 283.54 | 220.7 | 165.62 | 132.78 |
Levered Free Cash Flow | 784.59 | 922.06 | 820.41 | 574.26 | 411.54 |
Unlevered Free Cash Flow | 800.11 | 935.15 | 830.3 | 582.73 | 419.77 |
Change in Working Capital | -24.23 | -5.49 | -9.04 | -47.55 | -42.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.